Richard M. Murawski
Keine laufenden Positionen mehr
Profil
Richard M.
Murawski worked as a Plant Manager at Schering-Plough Corp.
from 1971 to 1990.
He then worked as an Operations Director at WelGen from 1990 to 1993, followed by a Vice President-Operations role at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. from 1994 to 1997.
From 1998 to 2002, he served as Vice President-Global Biotech Operations at Baxter BioScience Corp.
He then worked as Senior Vice President-Operations at Favrille, Inc. from 2002 to 2008, and as Chief Executive Officer at Murawski & Associates LLC from 2008 to 2010.
He was Vice President & General Manager at Dendreon Corp.
from 2010 to 2013.
He also held the position of Vice President-Manufacturing at Vital Therapies, Inc. and Senior Vice President-Operations at Evofem Biosciences, Inc. Murawski obtained an undergraduate degree from Newark College of Engineering.
Ehemalige bekannte Positionen von Richard M. Murawski
| Unternehmen | Position | Ende |
|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | 01.02.2013 |
| Murawski & Associates LLC | Chief Executive Officer | 01.07.2010 |
| Favrille, Inc. | Chief Operating Officer | 01.07.2008 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | 01.05.2002 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Chief Operating Officer | 01.01.1997 |
Ausbildung von Richard M. Murawski
| Newark College of Engineering | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVOFEM BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
| Favrille, Inc. | Health Technology |
WelGen
 WelGen Pharmaceuticals: MajorHealth Technology WelGen produces pharmaceutical and chemical products. | Health Technology |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
| Murawski & Associates LLC |
